Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00722748 · ClinicalTrials.gov registry record
Genomic Investigation of Cardiovascular Diseases
A clinical trial of Coronary Artery Disease and Atrial Fibrillation, sponsored by Scripps Translational Science Institute.
- Active
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT00722748: Active study of Coronary Artery Disease and Atrial Fibrillation, sponsored by Scripps Translational Science Institute.
NCT00722748 is a study of Coronary Artery Disease and Atrial Fibrillation that is active but no longer recruiting, run by Scripps Translational Science Institute. The registered enrollment target is 15,000 participants, above the 1,218-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1132% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00722748, a study of Coronary Artery Disease and Atrial Fibrillation, is active but no longer recruiting, sponsored by Scripps Translational Science Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal puts forward a research plan to initiate a genetic databank, henceforth referred to as The Genebank at Scripps Clinic Registry. This database will usher in genomic research at Scripps as we strive to stay at the forefront of cardiovascular research in the new century. Human subject donation allows for the creation of the proposed genebank.
Conditions Studied
Study Locations (1)
California
- Scripps Health - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2007-06 |
| Est. Completion | 2030-09 |
What the registry record for NCT00722748 still lists
NCT00722748 is an observational study that tracks outcomes without assigning an intervention. Its 15,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,218-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1132% higher).
The record links to 6 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00722748 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00722748 about?
NCT00722748 is a clinical study titled "Genomic Investigation of Cardiovascular Diseases". This proposal puts forward a research plan to initiate a genetic databank, henceforth referred to as The Genebank at Scripps Clinic Registry. This database will usher in genomic research at Scripps as we strive to stay at the forefront of cardiovascular research in the new century. Human subject don...
What is the current status of trial NCT00722748?
This trial is currently active not recruiting. The enrollment target is 15,000 participants. The study started on 2007-06. Estimated completion is 2030-09.
What conditions does trial NCT00722748 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Atrial Fibrillation, Myocardial Infarction, Aortic Stenosis, Mitral Regurgitation.
Who is sponsoring clinical trial NCT00722748?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00722748 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00722748's enrollment target sits among peer trials
15,000 5th of 219 higher than 215 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia